Transforming GxP Compliance: Why Deep Intelligence is the Only Path Forward for Life Sciences

The life sciences industry is currently defined by a stark contradiction. On one hand, we are witnessing a golden age of medical innovation driven by generative AI, precision medicine, and decentralized clinical trials. On the other hand, the underlying infrastructure used to ensure the safety and efficacy of these innovations is often tethered to a […]

The post Transforming GxP Compliance: Why Deep Intelligence is the Only Path Forward for Life Sciences first appeared on HHM Global | B2B Online Platform & Magazine.